NCT06793800 Effect of Transcutaneous Auricular Vagus Nerve Stimulation Application on Respiratory Functions in Stroke Patients
| NCT ID | NCT06793800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fenerbahce University |
| Condition | Hemiplegia |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2025-08-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-05 with a primary completion date of 2025-08-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation (TAVSS) in improving respiratory muscle strength and function in chronic stroke patients. It aims to explore TAVSS as a potential complementary approach in enhancing rehabilitation outcomes for this population.
Eligibility Criteria
Inclusion Criteria: * Being a chronic stroke patient with an ischemic or hemorrhagic stroke diagnosis made 1-3 years ago * Having been diagnosed with stroke for the first time * Ability to understand and follow simple verbal instructions * Being between the ages of 40 and 80 * No conditions affecting perioral muscles, such as facial paralysis or swallowing disorders * No visual, auditory, or communication problems * No cardiopulmonary disorders * No additional neurological, cardiovascular, orthopedic, or similar conditions causing balance problems * Mini Mental State Examination (MMSE) score ≥24 * No surgical operations or Botox applications in the last 6 months * Scoring 2 or below on the Modified Ashworth Scale Exclusion Criteria: * Presence of infection, ulcer, or scar on the auricle * Metallic implants in the skull, hypersensitivity, injury, or inflammation inside the ear * Chronic pulmonary and/or cardiac diseases * Resting heart rate below 60 beats per minute * Devices such as pacemakers or cochlear implants * Uncontrolled hypertension * Chronic obstructive pulmonary disease (COPD) or asthma unrelated to stroke * History of surgical operation or Botox application within the last 6 months * Presence of aphasia, apraxia, or neglect syndrome * History of 2 or more strokes (SVO) * Comorbid conditions affecting respiratory functions (e.g., Multiple Sclerosis, Parkinson's, spinal cord injury, contractures, deformities after fractures, active upper or lower respiratory infections, etc.) * Lack of cooperation
Contact & Investigator
Burcu AKKURT
STUDY DIRECTOR
Fenerbahce University
Frequently Asked Questions
Who can join the NCT06793800 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Hemiplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793800 currently recruiting?
Yes, NCT06793800 is actively recruiting participants. Contact the research team at burcu.akkurt@fbu.edu.tr for enrollment information.
Where is the NCT06793800 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06793800 clinical trial?
NCT06793800 is sponsored by Fenerbahce University. The principal investigator is Burcu AKKURT at Fenerbahce University. The trial plans to enroll 50 participants.